How the latest earnings event frames Vimian Group stock
Vimian Group (OM:VIMIAN) has investors’ attention after releasing third quarter and nine month 2026 results, with higher reported sales and net income than the same periods a year earlier.
That earnings release lands after a strong run in the Vimian Group share price, with a 30 day share price return of 17.9% and a year to date share price gain of 35.27% suggesting momentum has been building. Over a longer horizon, the total shareholder return sits at 36.6% over one year and 64.84% across three years, although investors who have held for five years have seen the total shareholder return fall 54.88%, which highlights how recent optimism follows a much tougher earlier period.
Scan beyond Vimian Group and spot other health-focused businesses with strong recent momentum using our hand picked 603 high quality undiscovered gems as a starting list.
Vimian Group now trades above both its own estimated value and the average analyst target after this sharp rebound. Is the market overcompensating for better results, or still applying justified caution?
Most Popular Narrative: 13% Overvalued
On the current narrative, Vimian Group screens as slightly expensive, with a fair value of SEK36.68 set against the latest SEK41.50 close. This puts extra weight on how the business earns and reinvests cash over time.
Expansion in high-margin, niche segments such as veterinary dental products and specialty pharmaceuticals, now supported by 75 product launches over 12 months, more than 60 products in the pipeline, and a new biologics focused R&D hub in France, points to continued mix shift toward higher value portfolios that can support revenue growth and adjusted EBITA margins.
See why 2 investors see Vimian Group as 13% overvalued.
Result: Fair Value of SEK36.68 (OVERVALUED)
Still, the story around Vimian Group only holds if working capital stops absorbing such a large share of cash and central costs remain under tighter control.
Find out about the key risks to this Vimian Group narrative.
Next Steps
If this all feels finely balanced, that is exactly the point. The quickest way to cut through the noise is to review the positives investors are focused on via our 2 key rewards.
Looking for more ideas beyond Vimian Group?
Do not stop with a single stock. Broader context from other opportunities can sharpen your judgment on risk, returns, and where Vimian Group fits in your portfolio.
- Target resilient potential by focusing on low volatility profiles through our 215 resilient stocks with low risk scores.
- Spot quality at a discount by scanning companies that look attractively priced on fundamentals using the 194 high quality undervalued stocks.
- Strengthen your income plan by reviewing businesses that combine higher yields with staying power in the 222 dividend fortresses.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com